Overview
Ryoko Suzuki practices practicing medicine in Koriyama, Japan.
Her clinical expertise encompasses Pleuropulmonary Blastoma and Small Cell Lung Cancer (SCLC).
She is actively involved in clinical research, co-authoring 16 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Ryoko Suzuki
Is Ryoko Suzuki a top-rated expert for Pleuropulmonary Blastoma?
MediFind is an objective health platform that identifies experts based on real-world data. Ryoko Suzuki is classified as an Experienced expert for Pleuropulmonary Blastoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Ryoko Suzuki participate in research or clinical trials?
Yes. Ryoko Suzuki has published 16 articles and abstracts on conditions like Pleuropulmonary Blastoma. You can view a list of Ryoko Suzuki's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Pleuropulmonary BlastomaMs. Suzuki isExperienced. Learn about Pleuropulmonary Blastoma.
- Small Cell Lung Cancer (SCLC)Ms. Suzuki isExperienced. Learn about Small Cell Lung Cancer (SCLC).